Treatment of colon cancer cells with NaBT activates PKD that induces the activity of SphK2 and stimulates its translocation from the nucleus into the cytosol where SphK2 accumulates and inhibits NaBT-induced apoptosis. The gene discussed is PRKD1; the disease is malignant colon neoplasm.